Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. In this article, we will discuss the ultrasound features of cystic hygroma, as well as the implications for patient care.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. It is usually diagnosed during pregnancy, often in the second trimester. The condition is characterized by a fluid-filled sac that is located in the neck, chest, or abdomen. Cystic hygroma can cause a variety of symptoms, including difficulty breathing, respiratory distress, and even cardiac problems.
Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. On ultrasound, cystic hygroma appears as a large, fluid-filled cyst with a thin wall. The cyst may be located in the neck, chest, or abdomen. It may also be associated with other anomalies, such as cardiac defects or skeletal abnormalities. The size of the cyst can vary, but it is typically larger than 5 cm in diameter. It may also have septations, which are thin walls that divide the cyst into smaller compartments. The cyst may also contain debris, which may appear as echogenic material on ultrasound.
The diagnosis of cystic hygroma has important implications for patient care. If the condition is detected during pregnancy, the patient should be closely monitored for any signs of respiratory distress or cardiac problems. In addition, the patient should be referred to a specialist for further evaluation and management. If cystic hygroma is detected after birth, the patient should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle. In some cases, medications may be used to reduce the size of the cyst.
Cystic hygroma is a rare congenital malformation caused by abnormal development of lymphatic vessels. Ultrasound is the primary imaging modality used to diagnose cystic hygroma, as it can provide detailed images of the affected area. The diagnosis of cystic hygroma has important implications for patient care, and patients should be referred to a specialist for further evaluation and management. Treatment may include surgical removal of the cyst or drainage of the cyst with a needle, as well as medications to reduce the size of the cyst.
1.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
2.
Investigating the Relationship Between GERD and Anxiety/Depression.
3.
In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.
4.
Indoor hydroponic gardening can improve mental health and quality of life for cancer patients
5.
Dr. Prerana S. Nesargi's message for Childhood Cancer Awareness Month 2023 is to increase understanding of pediatric oncology.
1.
How AI, Multi-Omics, and Real-World Evidence are Redefining Oncology Research and Shaping Cancer Care?
2.
Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact
3.
Vaccines that can help prevent cancer
4.
Innovative Strategies in Prostate Cancer Management: From Surveillance to Systemic Therapies
5.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
2.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation